Renaissance Technologies - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 79 filers reported holding UTAH MED PRODS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$17,674
-6.8%
205,514
+1.0%
0.03%
+11.1%
Q2 2023$18,956
-3.2%
203,392
-1.6%
0.03%
+3.8%
Q1 2023$19,590
-7.5%
206,714
-1.9%
0.03%
-10.3%
Q4 2022$21,173
-99.9%
210,614
-2.7%
0.03%
+11.5%
Q3 2022$18,471,000
-5.4%
216,514
-4.8%
0.03%
+13.0%
Q2 2022$19,531,000
-2.8%
227,370
+1.6%
0.02%
-4.2%
Q1 2022$20,103,000
-9.8%
223,714
+0.4%
0.02%
-14.3%
Q4 2021$22,291,000
+4.4%
222,914
-3.1%
0.03%0.0%
Q3 2021$21,356,000
+3.0%
230,035
-5.7%
0.03%
+7.7%
Q2 2021$20,742,000
-3.0%
243,914
-1.2%
0.03%
-3.7%
Q1 2021$21,383,000
+2.4%
246,914
-0.3%
0.03%
+17.4%
Q4 2020$20,884,000
+8.6%
247,737
+2.9%
0.02%
+21.1%
Q3 2020$19,234,000
-7.1%
240,814
+3.0%
0.02%
+5.6%
Q2 2020$20,712,000
-4.9%
233,714
+1.0%
0.02%
-14.3%
Q1 2020$21,774,000
-13.8%
231,514
-1.2%
0.02%
+10.5%
Q4 2019$25,272,000
+11.0%
234,214
-1.4%
0.02%0.0%
Q3 2019$22,763,000
-4.3%
237,514
-4.4%
0.02%
-9.5%
Q2 2019$23,783,000
+13.1%
248,514
+4.3%
0.02%
+10.5%
Q1 2019$21,025,000
+5.8%
238,248
-0.4%
0.02%
-13.6%
Q4 2018$19,874,000
-15.8%
239,214
-4.5%
0.02%
-8.3%
Q3 2018$23,605,000
-49.3%
250,583
-43.7%
0.02%
-4.0%
Q2 2018$46,567,000
+115.2%
445,222
+103.4%
0.02%
+4.2%
Q1 2018$21,640,000
+25.3%
218,922
+3.2%
0.02%
+26.3%
Q4 2017$17,273,000
+21.5%
212,200
+9.8%
0.02%
+11.8%
Q3 2017$14,217,000
+17.9%
193,300
+16.1%
0.02%
+13.3%
Q2 2017$12,058,000
+33.8%
166,545
+15.1%
0.02%
+15.4%
Q1 2017$9,015,000
-9.6%
144,700
+5.6%
0.01%
-18.8%
Q4 2016$9,967,000
+23.5%
137,000
+1.5%
0.02%
+14.3%
Q3 2016$8,073,000
-1.8%
135,000
+3.4%
0.01%
-12.5%
Q2 2016$8,222,000
+6.3%
130,500
+5.5%
0.02%
+6.7%
Q1 2016$7,738,000
+21.3%
123,731
+13.5%
0.02%
+7.1%
Q4 2015$6,381,000
+24.9%
109,000
+15.0%
0.01%
+16.7%
Q3 2015$5,107,000
-7.3%
94,800
+2.6%
0.01%
-7.7%
Q2 2015$5,510,000
+2.3%
92,400
+2.7%
0.01%
+18.2%
Q1 2015$5,387,000
+1.1%
90,000
+1.5%
0.01%
-15.4%
Q4 2014$5,326,000
+24.6%
88,700
+1.1%
0.01%
+8.3%
Q3 2014$4,276,000
-4.8%
87,700
+0.5%
0.01%
+20.0%
Q2 2014$4,491,000
-3.3%
87,300
+8.7%
0.01%
-9.1%
Q1 2014$4,644,000
+7.7%
80,300
+6.5%
0.01%
+10.0%
Q4 2013$4,310,000
+6.5%
75,400
+10.7%
0.01%0.0%
Q3 2013$4,048,000
+36.3%
68,100
+24.5%
0.01%
+25.0%
Q2 2013$2,970,00054,7000.01%
Other shareholders
UTAH MED PRODS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Clean Yield Group 27,400$2,956,0000.93%
THB ASSET MANAGEMENT 37,652$4,062,0000.75%
Ranger Investment Management 58,490$6,311,0000.42%
ISTHMUS PARTNERS, LLC 13,448$1,451,0000.33%
RICE HALL JAMES & ASSOCIATES, LLC 80,866$8,725,0000.30%
Ancora Advisors LLC 68,266$7,366,0000.27%
Cardinal Capital Management 9,694$1,046,0000.27%
Port Capital LLC 18,064$1,949,0000.22%
AFFINITY INVESTMENT ADVISORS, LLC 5,201$561,0000.20%
MORGAN DEMPSEY CAPITAL MANAGEMENT LLC 1,926$208,0000.08%
View complete list of UTAH MED PRODS INC shareholders